References
- Baumann H, Gauldia J. Acute phase response. Immunol Today 1994; 15: 74–80.
- Miwata H, Yamada T, Okada M, Kudo T, Kimura H, Morishima T. Serum amyloid A protein in acute viral infections. Arch Dis Child 1993; 68: 210–4.
- Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infec-tion. Lancet 1993; 341: 515–8.
- Gendrel D, Assicot M, Raymond J, Moulin F, Francoual C, Badoual J, Bohuon C. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 1996; 128: 570–3.
- Meisner M, Tschaikowsky K, Schnabel S, Schmidt J, Katalinic A, Schuttler J. Procalcitonin: influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur J Clin Chem Clin Biochem 1997; 35: 597–601.
- Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin: a new indicator of the systemic response to severe infections. Infections 1997; 25: 329–34.
- Werra I, Jaccard C, Corradin SB, Chiolero R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner JD, Glauser MP, Heumann D. Cytokine, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentra-tions: comparison in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25: 607–13.
- Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplas-matic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250— 6.
- Shimetani N, Shimetani K, Mori M. Level of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis. Scand J Clin Lab Invest 2001; 61: 567–74.
- National Committee for Clinical Laboratory Standards. How to define and utilize reference intervals in the clinical laboratory. NCCLS Doc 1992; 12: 1–47.
- Yamada T, Nomata Y, Sugita O, Okada M. A rapid method for measuring serum amyloid A protein by latex agglutination nephelometric immunoassay. Ann Clin Biochem 1993; 30: 72–6.
- Yamagishi Y, Sakurabayashi I, Iwata H, Kawai T. Sensitive quantitative determination of human serum CRP by latex photometric immunoassay. II. Serum CRP levels in healthy individuals and clinical significance of measuring sensitive quanti-tative determination. Jpn J Clin Pathol 1984; 32: 1389— 94.
- Maury CP. Comparative study of serum amyloid A protein and C-reactive protein in disease. J Clin Sci 1985; 68: 233–8.
- Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389: 39–48.
- Zajac JD, Martin TJ, Hudson P, Niall H, Jacobs JW. Biosynthesis of calcitonin by human lung cancer cells. Endocrinol 1985; 116: 749–55.
- Nylen ES, Snider RH, Thompson KA, Rohatgi P, Becker KL. Pneumonitis-associated hyperprocal-citonemia. Am J Med Sci 1996; 312: 12–8.
- Becker KL, Nylen ES, Snider R. La procalcitonin circule chez les sujets normaux. Ann Endocrinol 1996; Suppl 1: 59.
- Becker KL, Gazdar AF. What can the biology of small cell cancer of the lung teach us about the endocrine lung? Biochem Pharmacol 1985; 34: 155–9.
- Nylen ES, O'Neill W, Jordan MH, Snider RH, Moore CF, Lewis M, Silva OL, Becker KL. Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res 1992; 24: 439–42.
- Carsin H, Assicot M, Feger F, Roy O, Pennacino I, Le Bever H, Ainaud P, Bohuon C. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF-a and endotoxin levels early after thermal injury. Burns 1997; 23: 218–24.
- Shimetani N, Ichikawa K, Hachimura K, Tanaka T, Ohtani S, Kanoh Y, Ohtani H. Variations of serum amyloid A protein and interleukin-6 in patients with low concentration of serum C-reactive protein. Jpn J Clin Pathol 1996; 44: 669–75.